TITLE

Infections differ in two groups for 2 trials of Vascular Wrap

PUB. DATE
April 2008
SOURCE
Medical Device Daily;4/22/2008, Vol. 12 Issue 78, p2
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article reports that Angiotech Pharmaceuticals in April 2008 has suspended enrollments in the clinical trials for its Vascular Wrap device for hemodialysis in the U.S. and Europe. The move follows a report from the company's Data Safety Monitoring Board (DSMB), which reveals an imbalance of implant site infections in one of the two study groups. As reported, enrollments will be suspended until the company has reviewed the possible causes of the infections.
ACCESSION #
31780123

 

Related Articles

  • Angiotech in U.S. study with Vascular Wrap.  // Medical Technology & Devices Week;3/26/2007, Vol. 5 Issue 13, p2 

    The article reports on the enrollment of patients in Angiotech Pharmaceuticals' U.S. study on the Vascular Wrap paclitaxel-eluting mesh. The safety and efficacy of the Vascular Wrap will be evaluated in the study. The Vascular Wrap will be combined with the VaxSys ePTFE vascular graft. The study...

  • CLINIC ROUNDUP.  // BioWorld Today;4/22/2010, Vol. 21 Issue 77, p7 

    This section offers news briefs on clinical trials including the enrollment by Angiotech Pharmaceuticals Inc. of the first patient in its Formula PTX trial and the positive results obtained by Swedish Orphan Biovitrum AB from the second Kiobrina Phase II study.

  • Vascular Wrap study begins.  // Medical Device Daily;5/31/2007, Vol. 11 Issue 104, p8 

    The article reports on the initiation of a European study evaluating the safety and efficacy of the Vascular Wrap paclitaxel-eluting mesh from Angiotech Pharmaceuticals in 2007. The evaluation was conducted after surgical implantation with an ePTFE vascular graft in the upper extremity for...

  • BOSTON SCIENTIFIC GETS FDA DEVICE EXEMPTION FOR ATLAS.  // Biotech Equipment Update;Sep2004, p5 

    Angiotech Pharmaceuticals Inc., has reported that its corporate partner, Boston Scientific Corp. has received an Investigational Device Exemption from the U.S. Food and Drug Administration (FDA) to begin its ATLAS clinical trial. ATLAS is the first clinical trial using Boston Scientific's new...

  • Athersys, Angiotech begin MultiStem safety trial for AMI.  // Cardiovascular Devices & Drugs;Jan2008, Vol. 14 Issue 1, p24 

    The article reports that Athersys has received authorization from the U.S. Food and Drug Administration to begin a Phase I clinical trial evaluating the safety of MultiStem, Athersys' non-embryonic stem cell platform technology, in the treatment of acute myocardial infarction (AMI). Upon...

  • CLINIC ROUNDUP.  // BioWorld Today;5/31/2007, Vol. 18 Issue 105, p2 

    The article offers news briefs related to clinical trials for drugs. A study evaluating the safety and efficacy of the Vascular Wrap paclitaxel-eluting mesh was started by Angiotech Pharmaceuticals Inc. The enrollment for the Phase I dose-escalation study of ThermoDoxfor non-resectable liver...

  • Angiotech using cancer drug as anti-infective CVC coating. Ford, Omar // Medical Device Daily;12/20/2007, Vol. 11 Issue 231, p1 

    The article reports that Angiotech Pharmaceuticals has filed for FDA clearance of its anti-infective 5-Fluorouracil-coated (5-FU) Central Venous Catheter (CVC). The device is the latest product in the company's pipeline to help control the spread of deadly infections such as the...

  • REX MEDICAL/ANGIOTECH SIGN PACT FOR DIALYSIS CATHETER.  // Biotech Equipment Update;Jun2007, Vol. 15 Issue 6, p4 

    The article discusses the partnership of Rex Medical L.P. and Angiotech Pharmaceuticals Inc. for the development and distribution of Hemo-Stream Chronic Dialysis Catheter in the U.S. The Hemo-Stream technology is the first chronic hemodialysis catheter that is designed to eliminate the use of a...

  • Rex Medical in accord with Angiotech Pharmaceuticals.  // Medical Device Daily;4/30/2007, Vol. 11 Issue 82, p5 

    The article reports on the agreement between Angiotech Pharmaceuticals and Rex Medical which focuses on the development and distribution of the Hemo-Stream Chronic Dialysis Catheter. According to Rex, Hemo-Stream technology is the first catheter of its kind specifically for over-the-wire...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics